Product
Human erythropoietin
1 clinical trial
1 indication
Indication
Renal AnemiaClinical trial
A Phase Ⅱ Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Polyethylene Glycol Recombinant Human Erythropoietin Injection (CHO Cell) in Optimal Dose and Administration Regimen for Maintenance Therapy in Patients With Regular Dialysis Renal Anemia.Status: Recruiting, Estimated PCD: 2023-03-17